Objectives: Identify how the American Headache Society (AHS) membership manages status migrainosus (SM) among outpatients.
Background: SM is defined as a debilitating migraine attack lasting more than 72 h. There is no standard of care for SM, including whether a 72-h duration is required before the attack can be treated as SM.
Background: Headache is a frequent symptom following COVID-19 immunization with a typical onset within days post-vaccination. Cases of cerebral venous thrombosis (CVT) have been reported in adenovirus vector-based COVID-19 vaccine recipients.
Findings: We reviewed all vaccine related CVT published cases by April 30, 2021.